Impact Factor 2020: 1.226 (@Clarivate Analytics)
5-Year Impact Factor: 2.285 (@Clarivate Analytics)
Immediacy Index: 2.645
  • Users Online: 1671
  • Print this page
  • Email this page
This article has been cited by
1Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature
Juan Lu,Zhong-Yang Xie,Dan-Hua Zhu,Lan-Juan Li
World Journal of Clinical Cases.2021;9(7)1705
[DOI]
2Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
José María Díez,Carolina Romero,Júlia Vergara-Alert,Melissa Belló-Perez,Jordi Rodon,José Manuel Honrubia,Joaquim Segalés,Isabel Sola,Luis Enjuanes,Rodrigo Gajardo
Immunotherapy.2020;12(17)1247
[DOI]
3Challenges faced in establishing a dedicated 250 bed COVID-19 intensive care unit in a temporary structure
Shalendra Singh,George Cherian Ambooken,Rangraj Setlur,Shamik Kr Paul,Madhuri Kanitkar,Surinder Singh Bhatia,Ratnesh Singh Kanwar
Trends in Anaesthesia and Critical Care.2021;36(17)9
[DOI]
4SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development
Chiranjib Chakraborty,Manojit Bhattacharya,Bidyut Mallick,Ashish Ranjan Sharma,Sang-Soo Lee,Govindasamy Agoramoorthy
Expert Review of Clinical Pharmacology.2021;14(2)225
[DOI]
5Understanding COVID-19: From Origin to Potential Therapeutics
Muhammad Moazzam,Muhammad Imran Sajid,Hamza Shahid,Jahanzaib Butt,Irfan Bashir,Muhammad Jamshaid,Amir Nasrolahi Shirazi,Rakesh Kumar Tiwari
International Journal of Environmental Research and Public Health.2020;17(16)5904
[DOI]
6TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19
Mohammad Azam Ansari,Qazi Mohammad Sajid Jamal,Suriya Rehman,Ahmad Almatroudi,Mohammad A. Alzohairy,Mohammad N. Alomary,Takshashila Tripathi,Ali H. Alharbi,Syed Farooq Adil,Mujeeb Khan,M. Shaheer Malik
Arabian Journal of Chemistry.2020;13(11)8069
[DOI]
7SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics
Chiranjib Chakraborty,Ashish Ranjan Sharma,Manojit Bhattacharya,Rudra P. Saha,Sanmitra Ghosh,Soham Biswas,Saikat Samanta,Garima Sharma,Govindasamy Agoramoorthy,Sang-Soo Lee
Infection, Genetics and Evolution.2021;89(11)104729
[DOI]
8Response to: Status of Remdesivir: Not Yet Beyond Question!
Abinit Saha,Ashish Ranjan Sharma,Manojit Bhattacharya,Garima Sharma,Sang-Soo Lee,Chiranjib Chakraborty
Archives of Medical Research.2021;52(1)104
[DOI]
9Covid-19: a comprehensive review of a formidable foe and the road ahead
Arafat Hussain,Suniti Yadav,Vijay Hadda,Tejas M Suri,Pawan Tiwari,Saurabh Mittal,Karan Madan,Anant Mohan
Expert Review of Respiratory Medicine.2020;14(9)869
[DOI]
10Repurposing of the Herbals as Immune-Boosters in the Prevention and Management of COVID-19: A Review
Rinki Kumari,Anita Venaik,Md Al Hasibuzzaman,Simon Agongo Azure,Rudra P. Ojha,Ajay Kumar Sahi
Journal of Pure and Applied Microbiology.2021;15(1)1
[DOI]
11Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis
Masoumeh Adhami,Balal Sadeghi,Ali Rezapour,Ali Akbar Haghdoost,Habib MotieGhader
BMC Biotechnology.2021;21(1)1
[DOI]
12Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines
José Adão Carvalho Nascimento Júnior,Anamaria Mendonça Santos,Rafael Ciro Marques Cavalcante,Lucindo José Quintans-Júnior,Cristiani Isabel Banderó Walker,Lysandro Pinto Borges,Luiza Abrahão Frank,Mairim Russo Serafini
Drug Development and Industrial Pharmacy.2021;47(4)673
[DOI]
13In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs
Abhigyan Choudhury,Suprabhat Mukherjee
Journal of Medical Virology.2020;92(10)2105
[DOI]
14Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection
Soumya Ranjan Mahapatra,Susrita Sahoo,Budheswar Dehury,Vishakha Raina,Shubhransu Patro,Namrata Misra,Mrutyunjay Suar
Expert Review of Vaccines.2020;19(9)871
[DOI]
15Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
Federica Mannino,Alessandra Bitto,Natasha Irrera
Frontiers in Pharmacology.2020;11(9)871
[DOI]
16Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
Ratnadeep Saha,Pratik Ghosh,V. L. S. Prasad Burra
3 Biotech.2021;11(2)871
[DOI]
17Reported quality of life in countries with cases of COVID19: a systematic review
Maria Eduarda Melo-Oliveira,Danúbia Sá-Caputo,José Alexandre Bachur,Laisa Liane Paineiras-Domingos,Anelise Sonza,Ana Cristina Lacerda,Vanessa Mendonça,Adérito Seixas,Redha Taiar,Mario Bernardo-Filho
Expert Review of Respiratory Medicine.2021;15(2)213
[DOI]
18Are vanadium complexes druggable against the main protease Mpro of SARS-CoV-2? – A computational approach
Thomas Scior,Hassan H. Abdallah,Siti Fatimah Zaharah Mustafa,José Antonio Guevara-García,Dieter Rehder
Inorganica Chimica Acta.2021;519(2)120287
[DOI]
19Ten challenging questions about SARS-CoV-2 and COVID-19
Majid Teymoori-Rad,Saeed Samadizadeh,Alijan Tabarraei,Abdolvahab Moradi,Mahsa Bataghva Shahbaz,Alireza Tahamtan
Expert Review of Respiratory Medicine.2020;14(9)881
[DOI]
20A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics
Jyoti Verma,Naidu Subbarao
Archives of Virology.2021;14(9)881
[DOI]
21Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis
Roberto Ariel Abeldaño Zuñiga,Silvia Mercedes Coca,Giuliana Florencia Abeldaño,Ruth Ana María González-Villoria
Therapeutic Advances in Respiratory Disease.2021;15(9)175346662110072
[DOI]
22Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
Seyed Mehdi Sadat,Mohammad Reza Aghadadeghi,Masoume Yousefi,Arezoo Khodaei,Mona Sadat Larijani,Golnaz Bahramali
Molecular Biotechnology.2021;63(5)389
[DOI]
23Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex
Manojit Bhattacharya,Ashish Ranjan Sharma,Bidyut Mallick,Garima Sharma,Sang-Soo Lee,Chiranjib Chakraborty
Infection, Genetics and Evolution.2020;85(5)104587
[DOI]
24Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study
Anuja Pandit,Nirav Bhalani,B.L. Shashi Bhushan,Parshottam Koradia,Shweta Gargiya,Vinay Bhomia,Kevinkumar Kansagra
International Journal of Infectious Diseases.2021;105(5)516
[DOI]
25Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach
Samira Sanami,Milad Zandi,Behzad Pourhossein,Gholam-Reza Mobini,Mohsen Safaei,Atena Abed,Pooria Mohammadi Arvejeh,Fatemeh Amini Chermahini,Morteza Alizadeh
International Journal of Biological Macromolecules.2020;164(5)871
[DOI]
26Covid-19 vaccine, acceptance, and concern of safety from public perspective in the state of Odisha, India
Dibya Sundar Panda,Ranjan Kumar Giri,Anil Kumar Nagarajappa,Sakeenabi Basha
Human Vaccines & Immunotherapeutics.2021;164(5)1
[DOI]
27Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19
Xianfang Tang,Lijun Cai,Yajie Meng,JunLin Xu,Changcheng Lu,Jialiang Yang
Frontiers in Immunology.2021;11(5)1
[DOI]
28Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
Hong-Zhi Chen,Ling-Li Tang,Xin-Ling Yu,Jie Zhou,Yun-Feng Chang,Xiang Wu
Infectious Diseases of Poverty.2020;9(1)1
[DOI]
29Simulink Modelling For Simulating Intensive Care Mechanical Ventilators
Paolo Tamburrano,Pietro De Palma,Andrew R. Plummer,Elia Distaso,Riccardo Amirante
E3S Web of Conferences.2020;197(1)07007
[DOI]
30

Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey

Mohammed Al-Mohaithef,Bijaya Kumar Padhi
Journal of Multidisciplinary Healthcare.2020;Volume 13(1)1657
[DOI]
31A survey on COVID-19 vaccine acceptance and concern among Malaysians
S. A. R. Syed Alwi,E. Rafidah,A. Zurraini,O. Juslina,I. B. Brohi,S. Lukas
BMC Public Health.2021;21(1)1657
[DOI]
32Diagnosis for COVID-19: current status and future prospects
MD Alamgir Kabir,Rajib Ahmed,Sheikh Muhammad Asher Iqbal,Rasheduzzaman Chowdhury,Ramasamy Paulmurugan,Utkan Demirci,Waseem Asghar
Expert Review of Molecular Diagnostics.2021;21(3)269
[DOI]
33Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework
Neeraj Kumar,Damini Sood,Ramesh Chandra
RSC Advances.2020;10(59)35856
[DOI]
34Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review
Nidhi Chauhan,Shringika Soni,Abhinandan Gupta,Mohammad Aslam,Utkarsh Jain
Journal of Medical Virology.2021;93(4)1967
[DOI]
35Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude
Lei-Yun Wang,Jia-Jia Cui,Qian-Ying OuYang,Yan Zhan,Yi-Min Wang,Xiang-Yang Xu,Lu-Lu Yu,Hui Yin,Yang Wang,Chen-Hui Luo,Cheng-Xian Guo,Ji-Ye Yin
EPMA Journal.2021;93(4)1967
[DOI]